Dr. David Samadi Says Hidden Household Chemicals Raise Cancer Risk

Posted on April 30, 2018

Researchers say anti-mold cleaners, deodorizing products, detergents to clean and disinfect the surfaces of the house can increase, even double the danger of the appearance of breast cancer in women. In a previous published article about hidden cancer agents, Dr. David Samadi, head of urology at Lenox Hill Hospital says there are known chemicals that increase the risk of several cancers, like lung and breast cancer. In many cases, frequent use of these household cleaners can be similar to smoking up to twenty cigarettes a day.

Many different forms, whether liquids or powder form are usually deemed safe, although there have already been many problems linked to their biodegradability and the presence of phosphates. Scientists say these products contain hazardous substances, and the many molecules increase the probability of a tumor.

While there is no ban, scientists warn that there is a need to intensify controls to better analyze chemicals. In his published article, Dr. David Samadi lists several chemicals, and product names that heavily use toxic and carcinogenic chemicals, like laundry detergent and air fresheners.

One such ingredient, Formaldehyde is produced in high quantities worldwide, and is found in many consumer products. Dr. Samadi says Formaldehyde is harmful to health, it irritates the mucous membranes and can cause cancer in the nasopharynx when it is inhaled. Scientists conclude that this chemical substance in the nasopharynx can trigger tumors when inhaled.

Formaldehyde is a colorless substance, has a germicidal, preserving and disinfecting effect and is found in many everyday products, like disinfectants, household cleaners, cosmetics, paints and varnishes. It’s also highly carcinogenic. This chemical is used in food, listed as an additive to preserve food. It’s prevalent in so many areas of our lives that it’s difficult not to avoid it.

One way to reduce contact with formaldehyde or other toxic home chemicals is by adorning the home with houseplants. Plants introduce more oxygen into the home while eliminating toxins and free radicals. Dr. Samadi says it’s also important to ventilate rooms. This will help to avoid the accumulation in the rooms of chemicals released by the use of detergents, solvents, glues, furniture, etc.

Dr. David Samadi is currently the Chairman of Urology at Lenox Hill Hospital and former Director of Urlogy at Columbia Presbyterian Hospital. He’s one of the best known urologist, voted “Top Doctor” and “Best Doctor” for over a decade. Dr. Samadi developed The Samadi Modified Advanced Robotic Technique (SMART). Using a minimally invasive robotic-assisted surgery, Dr. Samadi modified the traditional open prostatectomy, which for years, used a different long incision, required a lengthy hospital stay, and took longer for patient recovery.

He’s authored more than 50 peer-reviewed medical papers, been honored with more than 30 awards, host a AM radio show and broadcasts Sunday Housecall, a medical informational segment that airs Sundays at 12:30 pm.

About Dr. David Samadi : insider.foxnews.com/tag/dr-david-samadi

Dr. David Samadi Says Inflammation Promotes Progression Of Prostate Cancer

Posted on April 05, 2018

According to world-renown urological doctor, Dr. David Samadi, chronic inflammation within the body unite many different health problems, including prostate cancer. Benign Prostatic Hyperplasia is the most frequently diagnosed urological pathology in men aged 50+ years. In fact, in three out of four patients with BPH there is a chronic inflammation that triggers the symptoms and promotes the progression of the disease. Just like when an insect stings, we take a bacterium or we have an allergic reaction, in the same way when the prostate is triggered by an acute inflammation. It’s one of the reasons Dr. David Samadi shines light on foods that naturally help your body’s defense mechanisms.

Foods Are Powerful Antioxidants

Lycopene is a particularly effective antioxidant, and twice as potent as beta carotene and ten times more than alpha tocopherol. Lycopene is also concentrated in some organs and, in particular, in the prostate. Studies have shown lower incidence of prostate cancer in populations that consume large quantities of tomato and tomato derivatives.
Researchers have reported that, in vitro, lycopene, associated with vitamin E, inhibits the growth of two different types of prostate cancer cells, and several studies have linked lycopene to a lower risk of cancer. One study revealed that men with higher blood lycopene concentrations present half the risk of contracting prostate cancer than those with lower concentrations.

Overall, the low consumption of foods and supplements rich in antioxidant compounds is associated with increased aggressiveness of prostate cancer. According to Dr. Samadi, adequate nutrition and the use of antioxidant-based supplements may represent a strategy to counteract the worsening of this widespread tumor.

During the past 20+ years, Dr. David Samadi has often considered the major and minor contributions of food, and how it impacts chronic disease. He’s one of the top minds and recognized experts in prostate cancer and robotic surgery. He is also known for his innovative SMART surgery techniques, which are less invasive, requires less surgical time, and a quicker recovery.

Dr. Samadi immigrated from Iran to London, then to New York. He grew up in Rosslyn New York, attended Stony Brook University, then completed his post-graduate internship and residency locally, at Montifiore Hospital, then Albert Einstein Hospital, both in the Bronx. Dr. Samadi also completed an oncology fellowship at Memorial Sloan Kettering Cancer Center.

From New York’s Columbia Presbyterian Hospital to Mount Sinai Medical Center to Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, Dr. David Samadi has become an internationally renowned surgeon with extensive surgery experience.

Read More: prostatecancer911.com/david-samadi/

What People Need to Learn from Cancer Treatment Centers of America

Posted on December 19, 2017

Many recognize the Cancer Treatment Centers of America name, and they realize that this is an outstanding cancer care network. What people can learn from this healthcare organization is that this company also makes a huge impact on cancer care education across the country and in many foreign places as well. This cancer care treatment and resource institution, continually shares what their highly trained staff and researchers figure out each day. They regularly consult with other cancer specialists and other doctors wanting to learn more regarding appropriate cancer treatments and more. Recently, CTCA worked with Labcorp volunteers and members of the NFL Alumni Association to provide incredible free screens that detected prostate cancer.

This screening drive was launched a few months ago, and Cancer Treatment Centers of America is still urging all men that are getting older to find a convenient screening location near their residences. A simple screen like this one has the potential to save boatloads of lives. People have to take advantage of the tests for this to occur. Cancer Treatment Centers of America is working around the clock to unravel the mysteries behind many cancers. They are responsible for many highly advanced cancer treatments in standard operation within healthcare facilities today.

The staff that seek to work at Cancer Treatment Centers of America quickly find out that all lives matter in the end. They believe in the provision for the best cancer treatments and care for each patient that ever walks through their doorways. Today, this cancer treatment facility operates a highly regarded research program devoted to finding more treatments, drugs and information related to cancer currently. Cancer Treatment Centers of America do advocate for more community wide available cancer screening programs like the one that this company helped perform just several months back with success.

Learn More About The Cancer Treatment Centers Of America

Posted on November 19, 2017

Allscripts and Nanthealth have partnered with Cancer Treatment Centers Of America to expand their already successful oncology department says, PRN Newswire. Thousands of cancer patients reach out to their network as a caring medical alternative to traditional cancer treatment. Their oncologists have been able to find evidence based treatment programs. Their new workflow program through their partnership with Nanthealth will help more patients get personalized care through a seamless method. You have a professional team of associates work diligently towards you getting better and live a better life when you’ve been diagnosed with cancer.

Get appropriate treatment options for your needs. They offer their clients safe and efficient treatment. You can leave a healthy longer life with accurate oncology reports that tell physicians exactly what you need. Choose to live a full life and go through the remission of cancEr with less worries of the cancer coming back. Their nontraditional method of treating cancer has been a preferred method for thousands of patients nationwide. They give you a comparison for other sources of cancer treatment. Their team of dedicated professionals is there to put the life of their patients first. Get the life you should be living with your battle with cancer.

You’re invited to visit one of their locations nationwide to find out your options for treatment. They also offer a unique website with more details and information on their success stories at Cancer Treatment Centers Of America. Live well with the top traditional cancer treatment alternative nationwide.

Visit More : http://www.myctca.com

Eric Lefkofsky, the Outstanding Entrepreneur that Cares for your Health

Posted on November 19, 2017

Health remains the most vital sector in all societies and anything that affects it means that the nation, in general, has a problem. In America, the issue is not any different. Over the recent years, health care has continuously shot up in the sense that if one compares its costs from way back in 1996 to present, the cost of health care is very high.

Some of the reasons that are found to be the cause include; continuous growth of population and aging, that is, more people are getting older, and this means that they need care and not just any attention but a special one. This means areas like homes for the aged have to be built and of course, this means finances. The high prices of healthcare are what leads to high spending by the patients when it comes to receiving care of any sort. The more common a disease is likely to affect people, the more its spending is escalated. For instance, numerous people have diabetes in various parts of the country, and a lot of money is spent on buying medicines. For back pain, neck pain, and others that affect so many are also costly. Although in this case, it’s not about drugs, and the care such patients are given like massage and other pain relieving procedures, which in turn becomes expensive.

Despite the high costs, all hope is not lost as organizations like Lefkofsky foundation are of excellent health. Out of the need for health care, Eric Lefkofsky who is the president of the foundation merged his Startup, Tempus, with Northwestern University’ Cancer center. After that, the CEO hired Kevin White, who is the top researcher in genetics thereby his work comes in handy to cancer patients noting that cancer is one of the worst diseases ever. More so, the prices of genetic sequencing have reduced.

Eric Lefkofsky is the CEO of Tempus has helped a lot in the health sector. He is an entrepreneur, his numerous involvements in different ventures in the society is of help. Also, he is a man with a big heart where he is helping the community via ventures like Lefkofsky foundation, which also considers children.

To Learn More Click Here

Clay Siegall is Changing Lives of Cancer Patients

Posted on October 16, 2017

Dr. Clay Siegall is one of the most successful biotechnologists in the world. At the moment, the scientist is based in the United States, and he is working hard to change the lives of numerous people who are living with the dangerous cancer disease. At the moment, Clay Siegall is working as the president for one of the leading biotechnology companies in the country, known as Seattle Genetics. The scientist is also the chairman of the institution. Seattle Genetics is an institution that specializes in the creating of therapies that cure diseases such as cancer. Most of the drugs developed by the private company have helped many people who are living with various conditions.

Clay Siegall has a rich educational background. According to his portfolio, the businessman went for his studies at the famous University of Maryland where he got his first degree in zoology. After some time, the scientist decided to go back to school and study genetics from the prestigious George Washington University.

As the founder and leader of the biotechnology company, Clay Siegall has been doing his best to ensure that customers living with cancer get the cure that they need. The company has been doing well, and it has been recognized in several platforms. The company recently released the first drug, and it has been doing well. According to Clay Siegall, the drug is already being used in over sixty nations, from all over the world. The people who have used the powerful drug have been cured, and more of them are living a healthy life.

In the modern world, many people are living with the cancer disease. The medication available in most countries causes serious side effects to the cancer patients, making things very difficult. People who use the traditional cancer treatment options die from the effects of the medications. Clay Siegall watched as one of his close relatives died from the condition. This motivated him to go to school and learn how to assist the people who are living with cancer. Since childhood, the businessman wanted to become a medical doctor, and this made things easier for him. Clay has changed the lives of so many people in the world.

How Eric Lefkofsky’s Colossal Genomic Database Will Benefit Cancer Patients

Posted on July 23, 2017

While Eric Lefkofsky graduated from the University of Michigan with a law degree, his real talent is being an entrepreneur who thrives on risk. In fact, Lefkofsky’s latest venture is genomics company, even though he has no medical background.

As the co-founder and CEO at Tempus, Lefkofsky oversees the compilation of a colossal database that physicians can use to personalize cancer therapies. Actually, Tempus is based on utilizing big data, as were Lefkofsky’s previous ventures, therefore it isn’t so unusual that he would compile gene-sequencing test results. With numerous Ph.D.s working at Tempus, Lefkofsky’s role is to bring the data together and make it simple for physicians to utilize. Tempus does this by partnering with hospitals that contribute data in return for software, which doctors will use to compare their cancer patient’s genetic profile to other profiles already in the database, in order to determine which treatments have been successful in similar cases.

In addition to co-founding Tempus, Lefkofsky also co-founded Lightbank, a venture fund that invests in diverse companies, especially startups employing disruptive technologies. Lefkofsky wrote a book titled Accelerated Disruption: Understanding the True Speed of Innovation, where he explains why businesses utilizing disruptive tactics often succeed where others fail. In his book, Lefkofsky warns potential entrepreneurs not to hesitate, because with technology, a competitor could easily overtake them and get their idea to market first.

A Chicago resident, Lefkofsky is active in his community; he sits on the boards of the Art Institute of Chicago, the Children’s Memorial Hospital and The Museum of Science and Industry. Adjunct Professor Eric Lefkofsky also teaches course on entrepreneurship at the University of Chicago Booth School of Business.

If anyone knows about entrepreneurship, it is Lefkofsky, who co-founded InnerWorkings, Echo Global Logistics, MediaBank and ThePoint.com. In his spare time, Lefkofsky oversees the Lefkofsky Foundation, which supports charitable causes around the world.

About Eric Lefkofsky: www.tempus.com/about-us/

Eric Lefkofsky, Tempus Co-Founder and CEO

Posted on May 10, 2017

Tempus, a genomic data company co-founded by Eric Lefkofsky gives physicians at the University of Chicago data to facilitate better treatment of their breast cancer patients. The Chicago-based Tempus announced a joint partnership with the University of Chicago Medicine. It will make available molecular sequencing and analysis to breast cancer specialists at the university to enable them to create individual treatments plans for their patients. Tempus offers to evaluate data for 1,000 breast cancer patients to assist the university physicians and researchers find out patterns to determine how patients will respond to treatment.

The purpose of molecular sequencing and analysis data will, eventually, lead to effective treatment and improved patients recovery results. “Although breast cancer is among the most common cancers, there is relatively little accessible data on the millions of patients who have battled the disease,” Dr. OlufunmilayoOlopade, professor and dean stated. “This forces too many physicians to make treatment decisions without the benefit of highly specific genetic information that could help them make better informed and precisely targeted decisions,” she added.

Mr Eric is an accomplished entrepreneur, investor, a philanthropist and an author. He is a Co-Founder and CEO of Tempus, a data company that provides molecular sequencing and analysis data technology use for the treatment of cancer. He is a founding partner of Lightbank, a company that provides venture capital investment in disruptive technology; the co-founder and Chairman of Groupon, a worldwide e-commerce marketplace; a co-founder of Uptake Technologies, a top predictive analytics platform for worldwide major industries; Mediaocean Company, a major provider of integrated media procurement technology; InnerWorkings Inc. a top provider of managed print and publicity solutions; and Echo Global Logistics company, a tech-enabled transportation and logistics subcontracting firm. He and his wife, Liz are co-chairs of Lefkofsky Family Foundation that advocates for high-impact community initiatives to improve lives in their communities. He chairs the Board of Trustees of Chicago’s Steppenwolf Theater; he is an adjunct professor at the University of Chicago and an author. He attended University of Michigan and hold a Juris Doctor (JD) degree from University of Michigan Law School.